HAP Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

HAP Trading’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-18,100	Closed	-$7.71K	–	909
2025 Q1	$7.71K	Buy	18,100 +300	+2%	+$26.8K	﹤0.01%	627
2024 Q4	$57.7K	Sell	17,800 -4,200	-19%	-$407K	0.01%	452
2024 Q3	$146K	Sell	22,000 -37,000	-63%	-$3.64M	0.02%	350
2024 Q2	$201K	Buy	+59,000	New	+$5.29M	0.02%	292
2024 Q1	–	Sell	-25,900	Closed	-$219K	–	1109
2023 Q4	$219K	Sell	25,900 -40,100	-61%	-$2.98M	0.03%	285
2023 Q3	$13.6K	Buy	66,000 +47,500	+257%	+$3.79M	﹤0.01%	734
2023 Q2	$55.2K	Buy	18,500 +2,400	+15%	+$201K	0.01%	482
2023 Q1	$35K	Sell	16,100 -16,900	-51%	-$1.4M	0.01%	628
2022 Q4	$47K	Sell	33,000 -1,600	-5%	-$130K	﹤0.01%	758
2022 Q3	$63K	Sell	34,600 -194,700	-85%	-$16.4M	﹤0.01%	914
2022 Q2	$586K	Sell	229,300 -342,600	-60%	-$25.7M	0.03%	405
2022 Q1	$309K	Buy	571,900 +307,800	+117%	+$28.4M	0.01%	699
2021 Q4	$80K	Buy	264,100 +12,800	+5%	+$1.54M	﹤0.01%	1306
2021 Q3	$210K	Buy	251,300 +234,900	+1,432%	+$30.2M	0.01%	1017
2021 Q2	$90K	Buy	+16,400	New	+$2.16M	﹤0.01%	1260
2021 Q1	–	Sell	-22,700	Closed	-$293K	–	2585
2020 Q4	$293K	Buy	+22,700	New	+$2.91M	0.01%	822
2019 Q3	–	Sell	-191,900	Closed	-$1.18M	–	1476
2019 Q2	$1.18M	Buy	191,900 +155,200	+423%	+$13.2M	0.09%	179
2019 Q1	$227K	Sell	36,700 -27,500	-43%	-$2.34M	0.02%	424
2018 Q4	$76K	Buy	64,200 +49,000	+322%	+$3.95M	﹤0.01%	687
2018 Q3	$43K	Sell	15,200 -164,200	-92%	-$15.9M	﹤0.01%	647
2018 Q2	$872K	Sell	179,400 -206,400	-53%	-$19M	0.04%	256
2018 Q1	$68K	Buy	385,800 +313,000	+430%	+$28.6M	﹤0.01%	601
2017 Q4	$139K	Sell	72,800 -1,000,600	-93%	-$83.8M	0.01%	539
2017 Q3	$1.55M	Buy	1,073,400 +841,800	+363%	+$67.5M	0.07%	193
2017 Q2	$329K	Buy	231,600 +97,300	+72%	+$6.9M	0.02%	427
2017 Q1	$213K	Sell	134,300 -235,600	-64%	-$15.8M	0.01%	469
2016 Q4	$192K	Sell	369,900 -731,600	-66%	-$45.2M	0.01%	476
2016 Q3	$1.54M	Buy	+1,101,500	New	+$68.1M	0.05%	188
2016 Q2	–	Sell	-220,700	Closed	-$452K	–	1058
2016 Q1	$452K	Sell	220,700 -160,900	-42%	-$8.36M	0.03%	304
2015 Q4	$457K	Buy	381,600 +88,900	+30%	+$6.06M	0.02%	391
2015 Q3	$218K	Sell	292,700 -137,200	-32%	-$10.8M	0.01%	496
2015 Q2	$1.02M	Buy	429,900 +392,400	+1,046%	+$30.5M	0.06%	261
2015 Q1	$12K	Buy	+37,500	New	+$2.62M	﹤0.01%	775
2014 Q4	–	Sell	-600,000	Closed	-$870K	–	1236
2014 Q3	$870K	Buy	+600,000	New	+$30.6M	0.03%	376
2014 Q2	–	Sell	-285,000	Closed	-$33K	–	1183
2014 Q1	$33K	Buy	+285,000	New	+$14.6M	﹤0.01%	837

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

HAP Trading's XBI Position: Q2 2024 in Review

HAP Trading sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 12,535 shares — an estimated $1.12M sold.

HAP Trading first reported a position in XBI in Q3 2015 and held it in 8 quarters. The position peaked at $60.9M in Q4 2021. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

HAP Trading reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
HAP Trading sold 12,535 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $1.12M.
HAP Trading first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and held it in 8 quarters.
HAP Trading's State Street SPDR S&P Biotech ETF position peaked at $60.9M in Q4 2021.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on HAP Trading's 13F filing for Q2 2024, filed 14 Aug 2024.